Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Increased serum levels of fractalkine and mobilisation of CD34+CD45 endothelial progenitor cells in systemic sclerosis

Fig. 3

Soluble endothelial biomarker concentrations in patients with systemic sclerosis (SSc) compared with healthy control subjects (HC). a Vascular endothelial growth factor (VEGF). b Endothelin-1. c Soluble fractalkine (s-Fractalkine). d Correlation between s-Fractalkine and CD34+CD45 endothelial progenitor cell (EPC) counts (nb). Correlation was established using the non-parametric Spearman’s correlation coefficient (r s ). * P < 0.05; *** P < 0.0005. n.s = non-significant

Back to article page